Postoperative vasoplegia in lung transplantation: incidence and relation to outcome.

[1]  D. Kaye,et al.  Vasoplegia Following Orthotopic Heart Transplantation: Prevalence, Predictors and Clinical Outcomes. , 2021, Journal of cardiac failure.

[2]  P. Hopkins,et al.  International consensus recommendations for anesthetic and intensive care management of lung transplantation. An EACTAIC, SCA, ISHLT, ESOT, ESTS, and AST approved document. , 2021, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[3]  Cale A. Kassel,et al.  The Use of Methylene Blue during Liver Transplantation for Vasoplegia , 2021, Case reports in anesthesiology.

[4]  J. Russell.  Vasopressor therapy in critically ill patients with shock , 2019, Intensive Care Medicine.

[5]  R. Cal,et al.  Risk factors for vasoplegia after cardiac surgery: a meta-analysis. , 2019, Interactive cardiovascular and thoracic surgery.

[6]  Andy Y Lee,et al.  Relation of Vasoplegia in the Absence of Primary Graft Dysfunction to Mortality Following Cardiac Transplantation. , 2018, The American journal of cardiology.

[7]  B. van Zaane,et al.  Vasoplegia after implantation of a continuous flow left ventricular assist device: incidence, outcomes and predictors , 2018, BMC Anesthesiology.

[8]  K. Khush,et al.  Increasing complexity of thoracic transplantation and the rise of multiorgan transplantation around the world: Insights from the International Society for Heart and Lung Transplantation Registry. , 2018, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[9]  L. Forni,et al.  Definitions and pathophysiology of vasoplegic shock , 2018, Critical Care.

[10]  Andy Y Lee,et al.  Determinants and Outcomes of Vasoplegia Following Left Ventricular Assist Device Implantation , 2018, Journal of the American Heart Association.

[11]  F. de Robertis,et al.  Use of taurolidine in lung transplantation for cystic fibrosis and impact on bacterial colonization† , 2018, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[12]  A. Kimmoun,et al.  Vasoplegia treatments: the past, the present, and the future , 2018, Critical Care.

[13]  P. Zarrini,et al.  Characterizing Predictors and Severity of Vasoplegia Syndrome After Heart Transplantation. , 2017, The Annals of thoracic surgery.

[14]  Jonathan Klick,et al.  Vasoplegia After Cardiovascular Procedures-Pathophysiology and Targeted Therapy. , 2017, Journal of cardiothoracic and vascular anesthesia.

[15]  P. Corris,et al.  Report of the ISHLT Working Group on Primary Lung Graft Dysfunction, part I: Definition and grading-A 2016 Consensus Group statement of the International Society for Heart and Lung Transplantation. , 2017, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[16]  J. Mehaffey,et al.  Methylene Blue for Vasoplegic Syndrome After Cardiac Operation: Early Administration Improves Survival. , 2017, The Annals of thoracic surgery.

[17]  Lynn M. Wilson,et al.  Risk assessment and outcomes of vasoplegia after cardiac surgery , 2017, General Thoracic and Cardiovascular Surgery.

[18]  K. Walley,et al.  Heparin-binding protein is important for vascular leak in sepsis , 2016, Intensive Care Medicine Experimental.

[19]  N. Kissoon,et al.  Early norepinephrine decreases fluid and ventilatory requirements in pediatric vasodilatory septic shock , 2016, Indian journal of critical care medicine : peer-reviewed, official publication of Indian Society of Critical Care Medicine.

[20]  J. Luketich,et al.  The ripple effect of a complication in lung transplantation: Evidence for increased long-term survival risk. , 2016, The Journal of thoracic and cardiovascular surgery.

[21]  D. Sessler,et al.  Increased Intraoperative Fluid Administration Is Associated with Severe Primary Graft Dysfunction After Lung Transplantation , 2016, Anesthesia and analgesia.

[22]  Jeremy S. Poppers,et al.  Methylene Blue for Vasoplegia When on Cardiopulmonary Bypass During Double-Lung Transplantation. , 2015, A & A case reports.

[23]  Z. Papp,et al.  Myeloperoxidase evokes substantial vasomotor responses in isolated skeletal muscle arterioles of the rat , 2015, Acta physiologica.

[24]  K. Nugent,et al.  Cardiac Vasoplegia Syndrome: Pathophysiology, Risk Factors and Treatment , 2015, The American journal of the medical sciences.

[25]  P. Evora,et al.  Twenty years of vasoplegic syndrome treatment in heart surgery. Methylene blue revised , 2014, Revista brasileira de cirurgia cardiovascular : orgao oficial da Sociedade Brasileira de Cirurgia Cardiovascular.

[26]  J. O. Pestana,et al.  Cardiopulmonary bypass increases the risk of vasoplegic syndrome after coronary artery bypass grafting in patients with dialysis-dependent chronic renal failure , 2014, Revista brasileira de cirurgia cardiovascular : orgao oficial da Sociedade Brasileira de Cirurgia Cardiovascular.

[27]  A. Khwaja.  KDIGO Clinical Practice Guidelines for Acute Kidney Injury , 2012, Nephron Clinical Practice.

[28]  R. Starling,et al.  Pre-operative risk factors and clinical outcomes associated with vasoplegia in recipients of orthotopic heart transplantation in the contemporary era. , 2012, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[29]  C. Detter,et al.  Myeloperoxidase deficiency preserves vasomotor function in humans , 2011, European heart journal.

[30]  J. Dekker,et al.  Plasma myeloperoxidase is inversely associated with endothelium-dependent vasodilation in elderly subjects with abnormal glucose metabolism. , 2010, Metabolism: clinical and experimental.

[31]  G. Fischer,et al.  Vasoplegia during cardiac surgery: current concepts and management. , 2010, Seminars in thoracic and cardiovascular surgery.

[32]  G. Fischer,et al.  Methylene blue for vasopressor-resistant vasoplegia syndrome during liver transplantation. , 2010, Journal of cardiothoracic and vascular anesthesia.

[33]  F. Sjöberg,et al.  Neutrophil-derived heparin binding protein--a mediator of increased vascular permeability after burns? , 2009, Burns : journal of the International Society for Burn Injuries.

[34]  L. Björck,et al.  Heparin-binding protein: an early marker of circulatory failure in sepsis. , 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[35]  Guocai Tao,et al.  Vasoplegic Syndrome During Liver Transplantation , 2009, Anesthesia and analgesia.

[36]  A. Fisher,et al.  Inhaled nitric oxide for modulation of ischemia-reperfusion injury in lung transplantation. , 2007, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[37]  M. Zou,et al.  Uncoupling of Endothelial Nitric Oxidase Synthase by Hypochlorous Acid: Role of NAD(P)H Oxidase–Derived Superoxide and Peroxynitrite , 2006, Arteriosclerosis, thrombosis, and vascular biology.

[38]  G. Saed,et al.  Myeloperoxidase up-regulates the catalytic activity of inducible nitric oxide synthase by preventing nitric oxide feedback inhibition , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[39]  L. Iversen,et al.  Heparin-binding protein (HBP/CAP37): A missing link in neutrophil-evoked alteration of vascular permeability , 2001, Nature Medicine.

[40]  M. Oz,et al.  Management of vasodilatory shock after cardiac surgery: identification of predisposing factors and use of a novel pressor agent. , 1998, The Journal of thoracic and cardiovascular surgery.

[41]  M. Oz,et al.  A prospective randomized trial of arginine vasopressin in the treatment of vasodilatory shock after left ventricular assist device placement. , 1997, Circulation.

[42]  P. Evora,et al.  Vasoplegic endothelial dysfunction in orthotopic liver transplantation. , 2016, Acta cirurgica brasileira.